01Dec
Americas Antitrust Review 2021
Covid-19 has made 2020 into a year like no other with ‘stay at home’ orders and working from home the new normal. Nonetheless, the tech and pharma industries continued to attract immense antitrust scrutiny, with daily reports in the media and pressure from politicians to address what some perceive to be anticompetitive mergers by digital platforms and pharmaceutical companies, even while innovation in both sectors continues at breakneck speed. In this article, we discuss some of the most...
By:
Cooley LLP
Related
In September, the Treasury Department issued final regulations governing hardship withdrawals from 4...
Read More >
Recently Lisa Felix, one of the experienced employment based immigration lawyers at Klasko Immigrati...
Read More >
The National Labor Relations Board (NLRB) has revisited the issue of when an employer may restrict a...
Read More >
In a recent decision, a majority of the National Labor Relations Board (NLRB) overturned an administ...
Read More >
In a recent published decision, the California Court of Appeal had the opportunity to address this i...
Read More >
This blog post is about walls and fences (but probably not the ones you may be thinking about). The ...
Read More >